Although its not yet confirmed if this risk applies to humans, individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 should avoid using tirzepatide
The country's expanding private healthcare sector demonstrates willingness to adopt new obesity pharmacotherapy despite high treatment costs
The GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist Market is undergoing a paradigm shift, transforming from a niche therapeutic class primarily used in type 2 diabetes management to a multi-billion-dollar market at the heart of the global obesity epidemic
A study showed that 12-week treatment with cinnamon (500 mg/day) decreased the percentage of fat mass and increased lean mass, improving overall body composition
Real Life Situation : A company sees a significant increase in their pharmacy spends as more employees begin prescriptions for Ozempic, Wegovy, Mounjaro or similar medications, putting pressure on their budgets
Neuropathic pain and diabetic neuropathy We identified 19 animal studies evaluating the role of GLP-1 in neuropathic pain [31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49]
